Perioperative medicine & outcomes

Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial

Reg Anesth Pain MedPublished Randomised controlled trial

Authors' conclusion

In this prospective, double-blind, randomized, placebo-controlled trial, continuous SAPB catheter infusion did not improve the primary outcome (QoR-40), and the observed differences in secondary outcomes should be interpreted as exploratory.

Study context

Population
Adults undergoing elective video-assisted thoracoscopic surgery (VATS)173 analysed
Participants
88 vs 85
Comparison
Serratus anterior plane block (SAPB) vs control
  • SAPBn = 88
  • Controln = 85reference
Primary endpoint
QoR-40 score
Follow-up
POD 1
Methodological detailsprospective, double-blind, placebo-controlled
  • Prospective
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

SAPB

176

median · range 166–184

Control

172

median · range 159–183

P = 0.1036

Secondary outcomes

Opioid consumption in recovery (IV MME) · significantly reduced with SAPB

P = 0.0388

Opioid consumption on POD 1 (IV MME) · significantly reduced with SAPB

P = 0.0349

Quality of recovery (QoR-40) score, postoperative day (POD) 2-4

Remained higher in SAPB across POD 2 to 4, not statistically significant

Hospital LOS

LOS lower with SAPB by 0.8 days, not statistically significant (2.69±1.76 vs 3.50±4.01)
P = 0.0872

Pain scores

Similar between groups

Safety

Complications and 30-day readmissions

Similar between groups

Original publication

Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial. Reg Anesth Pain Med. Published 23 June 2026. doi:10.1136/rapm-2026-107618

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.